Novavax | NVAX - Trade Debtors

Stock Price
8.45
Daily Change
-0.50 -5.59%
Monthly
-16.42%
Yearly
20.71%
Q1 Forecast
8.20

Novavax reported $106.45M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Adma Biologics USD 158.43M 20.76M Dec/2025
Agenus USD 22.44M 1.14M Dec/2025
AstraZeneca USD 19.05B 1.49B Dec/2025
BioCryst Pharmaceuticals USD 106.82M 15.49M Dec/2025
Cassava Sciences USD 120K 697K Dec/2025
Geron USD 37.66M 1.71M Sep/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
MannKind USD 38.37M 20.98M Dec/2025
Merck USD 12.12B 596M Sep/2025
Moderna USD 184M 862M Dec/2025
Novartis USD 12.29B 3.3B Dec/2025
Novavax USD 106.45M 72.27M Dec/2025
Pfizer USD 18.12B 2.02B Sep/2025
Sanofi EUR 397M 100M Dec/2025
Sarepta Therapeutics USD 398.23M 2.49M Dec/2025
TG Therapeutics USD 265.38M 33.86M Sep/2025